These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19305942)

  • 1. In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus.
    López C; Gil L; Lazo L; Menéndez I; Marcos E; Sánchez J; Valdés I; Falcón V; de la Rosa MC; Márquez G; Guillén G; Hermida L
    Arch Virol; 2009; 154(4):695-8. PubMed ID: 19305942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and self-assembly of virus-like particles of infectious hypodermal and hematopoietic necrosis virus in Escherichia coli.
    Hou L; Wu H; Xu L; Yang F
    Arch Virol; 2009; 154(4):547-53. PubMed ID: 19252812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maize rayado fino virus capsid proteins assemble into virus-like particles in Escherichia coli.
    Hammond RW; Hammond J
    Virus Res; 2010 Feb; 147(2):208-15. PubMed ID: 19914312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size and position of truncations in the carboxy-terminal region of major capsid protein VP1 of hamster polyomavirus expressed in yeast determine its assembly capacity.
    Gedvilaite A; Aleksaite E; Staniulis J; Ulrich R; Sasnauskas K
    Arch Virol; 2006 Sep; 151(9):1811-25. PubMed ID: 16575481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of recombinant capsids formed by the beta-annulus deletion mutant -- rCP (Delta48-59) of Sesbania mosaic virus.
    Pappachan A; Subashchandrabose C; Satheshkumar PS; Savithri HS; Murthy MR
    Virology; 2008 May; 375(1):190-6. PubMed ID: 18295296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsid-targeted viral inactivation can destroy dengue 2 virus from within in vitro.
    Qin CF; Qin ED
    Arch Virol; 2006 Feb; 151(2):379-85. PubMed ID: 16155726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cis-Acting sequences required for coat protein binding and in vitro assembly of Potato virus X.
    Kwon SJ; Park MR; Kim KW; Plante CA; Hemenway CL; Kim KH
    Virology; 2005 Mar; 334(1):83-97. PubMed ID: 15749125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus.
    Lazo L; Hermida L; Zulueta A; Sánchez J; López C; Silva R; Guillén G; Guzmán MG
    Vaccine; 2007 Jan; 25(6):1064-70. PubMed ID: 17097199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient strategy for the heterologous expression and purification of soluble Cowpea chlorotic mottle virus capsid protein and in vitro pH-dependent assembly of virus-like particles.
    Díaz-Valle A; García-Salcedo YM; Chávez-Calvillo G; Silva-Rosales L; Carrillo-Tripp M
    J Virol Methods; 2015 Dec; 225():23-9. PubMed ID: 26342905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotide and plasmid DNA packaging into polyoma VP1 virus-like particles expressed in Escherichia coli.
    Braun H; Boller K; Löwer J; Bertling WM; Zimmer A
    Biotechnol Appl Biochem; 1999 Feb; 29 ( Pt 1)():31-43. PubMed ID: 9889083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of polymorphism displayed by the coat protein mutants of tomato bushy stunt virus.
    Hsu C; Singh P; Ochoa W; Manayani DJ; Manchester M; Schneemann A; Reddy VS
    Virology; 2006 May; 349(1):222-9. PubMed ID: 16603216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-like particles of Macrobrachium rosenbergii nodavirus produced in bacteria.
    Goh ZH; Tan SG; Bhassu S; Tan WS
    J Virol Methods; 2011 Jul; 175(1):74-9. PubMed ID: 21536072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of anti-dengue capsid antibodies suggesting the N terminus region covering the first 20 amino acids of dengue virus capsid protein is predominantly immunogenic in mice.
    Puttikhunt C; Ong-Ajchaowlerd P; Prommool T; Sangiambut S; Netsawang J; Limjindaporn T; Malasit P; Kasinrerk W
    Arch Virol; 2009; 154(8):1211-21. PubMed ID: 19565324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shape and DNA packaging activity of bacteriophage SPP1 procapsid: protein components and interactions during assembly.
    Dröge A; Santos MA; Stiege AC; Alonso JC; Lurz R; Trautner TA; Tavares P
    J Mol Biol; 2000 Feb; 296(1):117-32. PubMed ID: 10656821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
    Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice.
    Valdés I; Bernardo L; Gil L; Pavón A; Lazo L; López C; Romero Y; Menendez I; Falcón V; Betancourt L; Martín J; Chinea G; Silva R; Guzmán MG; Guillén G; Hermida L
    Virology; 2009 Nov; 394(2):249-58. PubMed ID: 19783271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized sequential purification protocol for in vivo site-specific biotinylated full-length dengue virus capsid protein.
    Chong MK; Parthasarathy K; Yeo HY; Ng ML
    Protein Eng Des Sel; 2013 May; 26(5):377-87. PubMed ID: 23479673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Capsid-targeted viral inactivation for dengue virus infection].
    Qin CF; Jiang T; Chen SP; Yu M; Qin ED
    Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):111-5. PubMed ID: 15847175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines.
    Middelberg AP; Rivera-Hernandez T; Wibowo N; Lua LH; Fan Y; Magor G; Chang C; Chuan YP; Good MF; Batzloff MR
    Vaccine; 2011 Sep; 29(41):7154-62. PubMed ID: 21651936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of norovirus-like particles (VLPs) by ion exchange chromatography.
    Koho T; Mäntylä T; Laurinmäki P; Huhti L; Butcher SJ; Vesikari T; Kulomaa MS; Hytönen VP
    J Virol Methods; 2012 Apr; 181(1):6-11. PubMed ID: 22265819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.